Haleon (HLN) Notes Payables (2021 - 2024)
Haleon (HLN) posted Notes Payables of -$55.2 million for Q4 2024, up 96.99% on a QoQ basis from -$1.8 billion in Q2 2024, and up 11.07% year-over-year from -$49.7 million in Q1 2024.
Haleon (HLN) Notes Payables (2021 - 2024) Analysis & Trends
Haleon's Notes Payables history runs 4 years deep, the most recent figure standing at -$55.2 million for Q4 2024.
- Quarterly Notes Payables rose 11.07% year-over-year to -$55.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$55.2 million (up 11.07% YoY) and the FY2024 annual result came in at -$1.9 billion, down 132.96% from the prior year.
- Notes Payables was -$55.2 million for Q4 2024 at Haleon, up from -$1.8 billion in the prior quarter.
- Across five years, Notes Payables topped out at -$10.8 million in Q4 2021 and bottomed at -$1.8 billion in Q2 2024.
- A 4-year average of -$520.6 million and a median of -$207.2 million in 2022 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2022 — Notes Payables tumbled 693.98% — and 2023, when it climbed 27.52%.
- Haleon's Notes Payables stood at -$10.8 million in 2021, then plunged by 693.98% to -$85.6 million in 2022, then increased by 27.52% to -$62.1 million in 2023, then gained by 11.07% to -$55.2 million in 2024.
- Business Quant data shows HLN's Notes Payables at -$55.2 million in Q4 2024, -$1.8 billion in Q2 2024, and -$62.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -55.19 Mn |
| Jun 30, 2024 | -1.83 Bn |
| Dec 31, 2023 | -62.06 Mn |
| Jun 30, 2023 | -1.37 Bn |
| Dec 31, 2022 | -85.62 Mn |
| Sep 20, 2022 | -328.76 Mn |
| Jun 30, 2022 | -418.09 Mn |
| Dec 31, 2021 | -10.78 Mn |